Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Research & Development: 2018-2019

Historic Research & Development for DiaMedica Therapeutics (DMAC) over the last 2 years, with Dec 2019 value amounting to $1.8 million.

  • DiaMedica Therapeutics' Research & Development rose 24.19% to $1.8 million in Q4 2019 from the same period last year, while for Dec 2019 it was $7.9 million, marking a year-over-year increase of 74.70%. This contributed to the annual value of $19.1 million for FY2024, which is 45.36% up from last year.
  • DiaMedica Therapeutics' Research & Development amounted to $1.8 million in Q4 2019, which was up 11.44% from $1.6 million recorded in Q3 2019.
  • In the past 5 years, DiaMedica Therapeutics' Research & Development ranged from a high of $2.6 million in Q1 2019 and a low of $791,000 during Q1 2018.
  • In the last 2 years, DiaMedica Therapeutics' Research & Development had a median value of $1.5 million in 2018 and averaged $1.6 million.
  • Data for DiaMedica Therapeutics' Research & Development shows a peak YoY skyrocketed of 229.58% (in 2019) over the last 5 years.
  • Over the past 2 years, DiaMedica Therapeutics' Research & Development (Quarterly) stood at $1.5 million in 2018, then grew by 24.19% to $1.8 million in 2019.
  • Its Research & Development was $1.8 million in Q4 2019, compared to $1.6 million in Q3 2019 and $1.9 million in Q2 2019.